PCVX
Price
$68.97
Change
-$2.21 (-3.10%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
8.87B
62 days until earnings call
PLX
Price
$2.31
Change
-$0.02 (-0.85%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
171.57M
2 days until earnings call
Ad is loading...

PCVX vs PLX

Header iconPCVX vs PLX Comparison
Open Charts PCVX vs PLXBanner chart's image
Vaxcyte
Price$68.97
Change-$2.21 (-3.10%)
Volume$14.5K
Capitalization8.87B
Protalix BioTherapeutics
Price$2.31
Change-$0.02 (-0.85%)
Volume$16.2K
Capitalization171.57M
PCVX vs PLX Comparison Chart
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. PLX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and PLX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (PCVX: $70.24 vs. PLX: $2.32)
Brand notoriety: PCVX and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 130% vs. PLX: 89%
Market capitalization -- PCVX: $8.87B vs. PLX: $171.57M
PCVX [@Biotechnology] is valued at $8.87B. PLX’s [@Biotechnology] market capitalization is $171.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 3 bullish TA indicator(s).

  • PCVX’s TA Score: 4 bullish, 7 bearish.
  • PLX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PLX is a better buy in the short-term than PCVX.

Price Growth

PCVX (@Biotechnology) experienced а -11.48% price change this week, while PLX (@Biotechnology) price change was -2.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

PCVX is expected to report earnings on May 12, 2025.

PLX is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($8.87B) has a higher market cap than PLX($172M). PLX YTD gains are higher at: 23.404 vs. PCVX (-14.195). PLX has higher annual earnings (EBITDA): -6.48M vs. PCVX (-448.08M). PCVX has more cash in the bank: 1.75B vs. PLX (27.4M). PLX has less debt than PCVX: PLX (5.68M) vs PCVX (71.1M). PLX has higher revenues than PCVX: PLX (45.7M) vs PCVX (0).
PCVXPLXPCVX / PLX
Capitalization8.87B172M5,157%
EBITDA-448.08M-6.48M6,920%
Gain YTD-14.19523.404-61%
P/E RatioN/A13.00-
Revenue045.7M-
Total Cash1.75B27.4M6,376%
Total Debt71.1M5.68M1,251%
FUNDAMENTALS RATINGS
PLX: Fundamental Ratings
PLX
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXPLX
RSI
ODDS (%)
Bullish Trend 7 days ago
83%
Bearish Trend 7 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
84%
Momentum
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 7 days ago
77%
MACD
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 7 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
75%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend about 1 month ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
82%
Bullish Trend 7 days ago
87%
View a ticker or compare two or three
Ad is loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.58%
ORKA - PCVX
57%
Loosely correlated
+2.32%
RXRX - PCVX
41%
Loosely correlated
-1.82%
DNLI - PCVX
40%
Loosely correlated
+4.93%
DYN - PCVX
40%
Loosely correlated
-3.49%
VCEL - PCVX
39%
Loosely correlated
+3.29%
More

PLX and

Correlation & Price change

A.I.dvisor tells us that PLX and SRRK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLX and SRRK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+0.43%
SRRK - PLX
32%
Poorly correlated
+2.37%
SNDX - PLX
30%
Poorly correlated
-7.11%
PCVX - PLX
29%
Poorly correlated
-2.58%
MLTX - PLX
29%
Poorly correlated
+1.49%
CCCC - PLX
29%
Poorly correlated
-0.83%
More